Short Interest in Cingulate Inc. Drops By 13.5
CING Stock | USD 4.10 0.03 0.74% |
Roughly 53% of Cingulate's investor base is interested to short. The analysis of the overall investor sentiment regarding Cingulate suggests that many traders are impartial. The current market sentiment, together with Cingulate's historical and current headlines, can help investors time the market. In addition, many technical investors use Cingulate stock news signals to limit their universe of possible portfolio assets.
Cingulate |
Cingulate Inc. was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 77,200 shares, a decrease of 13.5 percent from the October 31st total of 89,200 shares. Based on an average daily volume of 317,300 shares, the short-interest ratio is
Read at thelincolnianonline.com
Cingulate Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Cingulate can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cingulate Fundamental Analysis
We analyze Cingulate's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cingulate using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cingulate based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Cingulate is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Cingulate Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cingulate stock to make a market-neutral strategy. Peer analysis of Cingulate could also be used in its relative valuation, which is a method of valuing Cingulate by comparing valuation metrics with similar companies.
Peers
Cingulate Related Equities
RZLT | Rezolute | 3.68 | ||||
ADAG | Adagene | 1.47 | ||||
PMVP | Pmv Pharmaceuticals | 0.67 | ||||
SNTI | Senti Biosciences | 0.75 | ||||
AVTE | Aerovate Therapeutics | 1.17 | ||||
ANTX | AN2 Therapeutics | 3.05 | ||||
DYAI | Dyadic International | 3.05 | ||||
GNLX | Genelux Common | 4.37 | ||||
ACRV | Acrivon Therapeutics, | 7.21 | ||||
ANEB | Anebulo Pharmaceuticals | 9.76 | ||||
IKT | Inhibikase Therapeutics | 13.42 | ||||
MNPR | Monopar Therapeutics | 20.54 |
Complementary Tools for Cingulate Stock analysis
When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |